Explore the words cloud of the HYPROTIN project. It provides you a very rough idea of what is the project "HYPROTIN" about.
The following table provides information about the project.
Coordinator |
UNIVERSITAT WIEN
Organization address contact info |
Coordinator Country | Austria [AT] |
Total cost | 1˙990˙728 € |
EC max contribution | 1˙990˙728 € (100%) |
Programme |
1. H2020-EU.1.1. (EXCELLENT SCIENCE - European Research Council (ERC)) |
Code Call | ERC-2018-STG |
Funding Scheme | ERC-STG |
Starting year | 2019 |
Duration (year-month-day) | from 2019-03-01 to 2024-02-29 |
Take a look of project's partnership.
# | ||||
---|---|---|---|---|
1 | UNIVERSITAT WIEN | AT (WIEN) | coordinator | 1˙990˙728.00 |
HYPROTIN proposes a pioneering research platform for hyperpolarized magnetic resonance of breast-cancer related proteins that will revolutionize our view on tumorigenesis at the atomic level, through bottom-up reconstitution of medicinal relevant interaction pathways involving the breast cancer susceptibility protein 1 (BRCA1). The risk to develop a hereditary breast or ovarian cancer (HBOC) increases to 55-65 % upon mutation of the BRCA1 gene. Yet, little is known about the biochemistry of tumorigenesis, so that drugs directed towards molecular targets are not satisfactory. To date, mastectomy remains the only preventive treatment. This dramatic lack of knowledge is a consequence of BRCA1 being an intrinsically disordered protein (IDP). Recognizing the importance of IDPs has revolutionized structural biology in the last decade, but this also represents a huge experimental challenge. To date, nuclear magnetic resonance (NMR) is the only technique available to study IDPs at high resolution. However, several limits of the technique must be overcome. Its low sensitivity impedes investigations under biologically meaningful conditions, so that new approaches are required. The HYPROTIN project aims to achieve two methodological goals: 1) Residue-resolved studies of the BRCA1 IDP under physiological conditions; and 2) real-time monitoring of BRCA1-ligand binding, thereby adding a time-resolved dimension to the NMR characterization of IDPs. This systematic approach will provide unprecedented insight into the BRCA1 interactome, provide medically relevant data and residue-resolved protein interaction kinetics. This will open a new knowledge base for rational drug design. The project will employ cutting-edge equipment that is unique worldwide, and will represent the first facility in Europe suited for these ground-breaking experiments. The PI has unique interdisciplinary experience enabling the demanding hyperpolarization approach to IDPs.
year | authors and title | journal | last update |
---|---|---|---|
2020 |
Gregory L. Olsen, Or Szekely, Borja Mateos, Pavel Kadeřávek, Fabien Ferrage, Robert Konrat, Roberta Pierattelli, Isabella C. Felli, Geoffrey Bodenhausen, Dennis Kurzbach, Lucio Frydman Sensitivity-enhanced three-dimensional and carbon-detected two-dimensional NMR of proteins using hyperpolarized water published pages: 161-171, ISSN: 0925-2738, DOI: 10.1007/s10858-020-00301-5 |
Journal of Biomolecular NMR 74/2-3 | 2020-04-15 |
2019 |
Sami Jannin, Jean-Nicolas Dumez, Patrick Giraudeau, Dennis Kurzbach Application and methodology of dissolution dynamic nuclear polarization in physical, chemical and biological contexts published pages: 41-50, ISSN: 1090-7807, DOI: 10.1016/j.jmr.2019.06.001 |
Journal of Magnetic Resonance 305 | 2019-09-04 |
2019 |
Giuseppe Sicoli, Hervé Vezin, Karin Ledolter, Thomas Kress, Dennis Kurzbach Conformational tuning of a DNA-bound transcription factor published pages: 5429-5435, ISSN: 0305-1048, DOI: 10.1093/nar/gkz291 |
Nucleic Acids Research 47/10 | 2019-08-05 |
2019 |
Thomas Kress, Astrid Walrant, Geoffrey Bodenhausen, Dennis Kurzbach Long-Lived States in Hyperpolarized Deuterated Methyl Groups Reveal Weak Binding of Small Molecules to Proteins published pages: 1523-1529, ISSN: 1948-7185, DOI: 10.1021/acs.jpclett.9b00149 |
The Journal of Physical Chemistry Letters | 2019-05-28 |
Are you the coordinator (or a participant) of this project? Plaese send me more information about the "HYPROTIN" project.
For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.
Send me an email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.
Thanks. And then put a link of this page into your project's website.
The information about "HYPROTIN" are provided by the European Opendata Portal: CORDIS opendata.